Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An update from AbCellera Biologics (ABCL) is now available.
On May 7, 2024, during its earnings call, the Company will review its first-quarter results, supported by a corporate presentation. The information provided, including any exhibits, is for informational purposes and is not considered legally filed under the Securities Exchange Act, nor is it incorporated into any official filings, unless explicitly stated.
Find detailed analytics on ABCL stock on TipRanks’ Stock Analysis page.
